Grail Investor Securities Class Action
Grail · NHS-Galleri trial · Ongoing Litigation
About this case
Investors allege that GRAIL made false or misleading statements about the prospects and results of its NHS-Galleri trial, including whether the study's three-year timeframe could demonstrate its primary endpoint, causing investor losses when the information was disclosed. The securities class action is ongoing, and the class has not yet been certified.
Case overview
- Defendant company
- Grail
- Product or service
- NHS-Galleri trial
- Case name
- Robbins v. Grail, Inc.
- Court case number
- 26-cv-05428
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
- Grail Lead Plaintiff Application
Participation information
Lead Plaintiff Application
Shareholders who purchased GRAIL shares during the May 13, 2025 to February 19, 2026 class period and allegedly suffered a loss could seek appointment as lead plaintiff.
Contact Schall, Brown & Schwartz LLP regarding a possible lead plaintiff appointment.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
Grail Lead Plaintiff Application
The notice describes an opportunity for investors who purchased Grail securities during the stated class period and allegedly suffered losses to seek appointment as lead plaintiff.
A lead-plaintiff motion had to be filed with the court no later than August 4, 2026. Investors could contact Glancy Prongay Wolke & Rotter LLP or retain counsel of their choice. Investors who did not seek lead-plaintiff status could take no action and remain absent class members.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
Grail Investor Legal Rights Inquiry
The law firm invites individuals who purchased Grail shares between May 13, 2025 and February 19, 2026 and experienced an investment loss to discuss their legal rights.
Contact Marshall P. Dees, Esq. by email or telephone, or visit the firm's website for more information.
- Type
- Law Firm Signup
- Reported proof requirement
- Unclear
GRAIL Class Action Legal Consultation
People who purchased or acquired GRAIL common stock between May 13, 2025, and February 19, 2026, are invited to discuss their legal rights with the law firm.
Call Bragar Eagel & Squire at (212) 355-4648 to discuss legal rights.
- Type
- Law Firm Signup
- Reported proof requirement
- Unclear
Sources
- GRAIL Securities Fraud Class Action
Barchart.com ·
- Grail Securities Fraud Class Action
Barchart.com ·
- GRAIL Securities Fraud Class Action
Barchart.com ·
- GRAIL Securities Fraud Class Action
Benzinga ·
- GRAIL Securities Class Action
Benzinga ·
- GRAIL Securities Fraud Class Action
Barchart.com ·
- GRAIL Investor Securities Class Action
Barchart.com ·
- GRAIL Investor Securities Fraud Class Action
Benzinga ·
- GRAIL Securities Fraud Class Action
Barchart.com ·
- GRAIL Securities Fraud Class Action
Morningstar ·
- Grail Securities Fraud Class Action
Barchart.com ·
- GRAIL Securities Class Action
Barchart.com ·
- GRAIL Securities Class Action Lawsuit
Barchart.com ·
- Grail Investor Securities Class Action
Benzinga ·